DexCom, Inc.
| Security | DXCM / DexCom, Inc. |
| Insider | Kyle Malady |
This page shows the track record and history of Malady Kyle
insider trades in DexCom, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Kyle Malady in DXCM / DexCom, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Kyle Malady in DXCM / DexCom, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-09 | 2025-09-05 | 4 | Malady Kyle | DXCM | Common Stock | D | 80.8600 | -667 | -54 | 22,667 | ||||
| 2025-05-12 | 2025-05-08 | 4 | Malady Kyle | DXCM | Common Stock | D | 5,192 | 23,334 | ||||||
| 2024-05-24 | 2024-05-22 | 4 | Malady Kyle | DXCM | Common Stock | D | 2,613 | 18,142 | ||||||
| 2023-05-22 | 2023-05-18 | 4 | Malady Kyle | DXCM | Common Stock | D | 0.0010 | 2,885 | 0 | 15,529 | ||||
| 2022-05-23 | 2022-05-20 | 4 | Malady Kyle | DXCM | Common Stock | D | 0.0010 | 979 | 0 | 3,161 | ||||
| 2021-05-25 | 2021-05-21 | 4 | Malady Kyle | DXCM | Common Stock | D | 0.0010 | 910 | 0 | 2,182 | ||||
| 2020-10-13 | 2020-10-11 | 4 | Malady Kyle | DXCM | Common Stock | D | 0.0010 | 1,272 | 0 | 1,272 |
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)
